Sanne de Bruin

232 List of publications Vlaar APJ, LimEHT, de Bruin S The anti-C5a antibody vilobelimab efficiently inhibits C5a in severe COVID-19 patients. Clinical and Translational Science 2021, in press Vlaar APJ, de Bruin S, Brouwer MC, et al. Efficacy matters: broadening complement inhibition in COVID-19 - Authors’ reply. Lancet Rheumatol [Internet]. 2021 Feb;3(2):e95–6. Harmon MBA, Heijnen NFL, de Bruin S , et al. Induced normothermia ameliorates the procoagulant host response in human endotoxaemia. Br J Anaesth. 2021;126(6):1111-1118. doi:10.1016/j.bja.2021.02.033 Larsen MD, de Graaf EL, Sonneveld ME, et al. Afucosylated IgG characterizes en- veloped viral responses and correlates with COVID-19 severity. Science (80- ). 2021;371(6532):eabc8378. doi:10.1126/science.abc8378 Wijnberge M, RellumSR, de Bruin S , et al. Erythropoiesis-stimulating agents as replace- ment therapy for blood transfusions in critically ill patients with anaemia: A systematic review with meta-analysis. Transfus Med. September 2020. doi:10.1111/tme.12715 Vlaar APJ, de Bruin S , Busch M, et al. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020;(Septem- ber):19-21. doi:10.1016/S2665-9913(20)30341-6 Vlaar AP, Oczkowski S, de Bruin S , et al. Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Med- icine. Intensive Care Med. January 2020. doi:10.1007/s00134-019-05884-8 Vogelzang EH, Loeff FC, Derksen NIL, et al. Development of a SARS-CoV-2 Total Anti- body Assay and the Dynamics of Antibody Response over Time in Hospitalized and Non- hospitalized Patients with COVID-19. J Immunol. 2020;205(12):3491-3499. doi:10.4049/ jimmunol.2000767 Driedonks TAP, Mol S, Bruin S , et al. Y-RNA subtype ratios in plasma extracellular ves- icles are cell type- specific and are candidate biomarkers for inflammatory diseases. J Extracell Vesicles. 2020;9(1):1764213. doi:10.1080/20013078.2020.1764213